GILEAD SCIENCES, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Gilead Sciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Gilead Sciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$297M, a 303% decline year-over-year.
  • Gilead Sciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $62M, a 95.6% decline year-over-year.
  • Gilead Sciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.25B, a 0.08% decline from 2022.
  • Gilead Sciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.25B, a 39.9% decline from 2021.
  • Gilead Sciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $2.08B, a 31.5% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $62M -$297M -$443M -303% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $505M $438M -$111M -20.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $616M -$315M -$631M -200% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.25B $236M -$162M -40.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $1.41B $146M -$500M -77.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.91B $549M +$181M +49.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.73B $316M +$480M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $1.25B $398M +$15M +3.92% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $1.23B $646M -$206M -24.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.44B $368M +$68M +22.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $1.37B -$164M -$706M -130% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.08B $383M +$113M +41.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $1.96B $852M +$380M +80.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $1.58B $300M -$73M -19.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.66B $542M +$77M +16.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $1.58B $270M +$1.06B Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $522M $472M +$805M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$283M $373M -$162M -30.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$121M $465M +$83M +21.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$204M -$788M -$1.8B -178% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $1.6B -$333M -$898M -159% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $2.5B $535M +$268M +100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $2.23B $382M -$112M -22.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2.34B $1.01B -$4.95B -83% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $7.29B $565M -$394M -41.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $7.68B $267M -$779M -74.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $8.46B $494M -$424M -46.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $8.89B $5.96B +$5.14B +626% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $3.74B $959M +$8M +0.84% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $3.74B $1.05B +$144M +16% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $3.59B $918M -$17M -1.82% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $3.61B $821M +$69M +9.18% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $3.54B $951M +$71M +8.07% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $3.47B $902M -$112M -11% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $3.58B $935M +$28M +3.09% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $3.55B $752M -$16M -2.08% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $3.57B $880M +$233M +36% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $3.34B $1.01B +$358M +54.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $2.98B $907M +$181M +24.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $2.8B $768M +$442M +136% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $2.36B $647M +$353M +120% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $2B $656M +$348M +113% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $1.65B $726M +$504M +226% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $1.15B $326M +$63M +23.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 $1.09B $294M +$14.4M +5.15% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $1.07B $308M +$44.5M +16.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $1.03B $222M -$8.86M -3.83% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $1.04B $263M +$106M +67.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $932M $280M +$42.6M +17.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $889M $264M +$23.4M +9.74% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $866M $231M +$4.02M +1.77% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $862M $157M -$16.1M -9.28% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $878M $237M -$21.4M -8.28% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $899M $240M -$43.9M -15.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $943M $227M -$80.5M -26.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $1.02B $173M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $259M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $284M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $308M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.